-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Cartesian Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q1 2015 to Q3 2024.
- Cartesian Therapeutics, Inc. Revenues for the quarter ending September 30, 2024 was $387K, a 94.1% decline year-over-year.
- Cartesian Therapeutics, Inc. annual Revenues for 2017 was $207K, a 97.4% decline from 2016.
- Cartesian Therapeutics, Inc. annual Revenues for 2016 was $8.08M, a 34.5% increase from 2015.
- Cartesian Therapeutics, Inc. annual Revenues for 2015 was $6.01M, a 97.7% increase from 2014.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)